Please login to the form below

Not currently logged in
Email:
Password:

Avidity Biosciences

This page shows the latest Avidity Biosciences news and features for those working in and with pharma, biotech and healthcare.

Lilly invests in antibody oligonucleotides conjugates with Avidity deal

Lilly invests in antibody oligonucleotides conjugates with Avidity deal

Avidity Biosciences. ... Avidity's platform seeks to overcome the delivery challenges of oligonucleotides, RNA-targeting drugs which hold huge promise in reaching currently 'undruggable' targets.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Syneos Health®

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...

Latest intelligence

Virtual meeting technologies for reducing emissions and waste in the healthcare industry
...
Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...